Medicines containing Risankizumab for 2026
We are seeking recurring deliveries of medicines containing the active ingredient Risankizumab for the year 2026. This ensures the continuous supply for patients.
CONTRACTING AUTHORITY
Name
Fakultní nemocnice Olomouc
City
Olomouc - Nová Ulice
Country
CZ
CLASSIFICATION
Procedure Type
Open Procedure
Contract Type
Supplies
Main CPV
33652300, Immunosuppressive agents.
ADDITIONAL DETAILS
EU Funded
Yes
Suitable for SMEs
Yes
Electronic Submission
Required
Legal Basis
32014L0024
DEADLINES & TIMELINE
Submission Deadline
30 days remaining(LOT-0001)
Published